MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647067340 A) filed by Leads Biolabs Inc. on May 29, 2026, for Antibody Binding To Bcma And Multispecific Antibody Comprising Same.
Inventors include Sun, Jianming; Ding, Mi; Qin, Yurong; Huang, Xiao Number; and Ling, Hong.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: A monoclonal antibody specifically binding to BCMA, a BCMA- and CD3-targeted bispecific antibody constructed on the basis of said monoclonal antibody, and a BCMA/GPRC5D/CD3-targeted trispecific antibody. Also provided are a nucleic acid molecule encoding the antibody, an expression vector for expressing the antibody, a host cell and a method. Also provided are an immunoconjugate, a bispecific molecule, a trispecific molecule and a pharmaceutical composition comprising the antibody, and a diagnosis and treatment method using the anti-BCMA antibody, the BCMA/CD3-targeted bispecific antibody or the BCMA/GPRC5D/CD3-targeted trispecific antibody.
Disclaimer: Curated by HT Syndication.
